首页> 美国卫生研究院文献>Springer Open Choice >Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature
【2h】

Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature

机译:口服甲氨蝶呤治疗特发性肥厚性颅脑膜炎:一例病例并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Idiopathic hypertrophic cranial pachymeningitis (IHCP) is a rare clinical entity, characterized by a chronic inflammation causing thickening of the dura. Adequate therapeutic management is still a matter of debate. We present a patient with an IHCP, non-responsive to corticotherapy. Oral methotrexate was introduced (12.5 mg weekly) and total remission was observed after 6 weeks, both clinically and after neuro-imaging. We conclude that methotrexate can be effective and a therapeutical option in patients with IHCP who are resistant to corticotherapy or present major side-effects of chronic corticosteroids use.
机译:特发性肥厚性颅脑膜脑膜炎(IHCP)是一种罕见的临床实体,其特征是慢性炎症导致硬脑膜增厚。充分的治疗管理仍是一个有争议的问题。我们为患者提供对皮质疗法无反应的IHCP。口服甲氨蝶呤(每周12.5 mg),并在临床和神经影像学检查后6周观察到总缓解。我们得出的结论是,甲氨蝶呤对于抵抗皮质激素治疗或目前长期使用皮质类固醇激素有重大副作用的IHCP患者可能是有效的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号